日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiovascular disease and radiopharmaceutical therapies- an underestimated risk?

心血管疾病与放射性药物疗法——被低估的风险?

Lassmann, Michael; Eberlein, Uta; Verburg, Frederik A

Optical (Cherenkov) dosimetry to unravel the radiobiological effects of radioisotope based therapy

利用光学(切伦科夫)剂量测定法揭示放射性同位素疗法的放射生物学效应

Van Leeuwen, Fijs W B; Pouget, Jean-Pierre; Lassmann, Michael

EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses

欧洲核医学协会专家意见:如何将放射生物学的经验应用于临床试验设计?第一部分:回归吸收剂量反应和阈值吸收剂量的基础知识

Pouget, Jean-Pierre; Gabina, Pablo Minguez; Herrmann, Ken; Deandreis, Desirée; Konijnenberg, Mark; Taieb, David; van Leeuwen, Fijs W B; Kurth, Jens; Eberlein, Uta; Lassmann, Michael; Lückerath, Katharina

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer

放射性碘消融治疗成功的预测因素:一项针对甲状腺癌的MEDIRAD前瞻性临床研究的结果

Taprogge, Jan; Murray, Iain; Sharman, Hannah; Gape, Paul; Leek, Francesca; Abreu, Carla; Vávrová, Lenka; Newbold, Kate; Wong, Kee H; Luster, Markus; Verburg, Frederik A; Schurrat, Tino; Vija, Lavinia; Courbon, Frédéric; Vallot, Delphine; Bardiès, Manuel; Schumann, Sarah; Eberlein, Uta; Lassmann, Michael; Flux, Glenn

Non-linear mixed-effects modelling and population-based model selection for (131)I kinetics in benign thyroid disease

非线性混合效应模型和基于人群的模型选择用于研究良性甲状腺疾病中 (131)I 的动力学

Hardiansyah, Deni; Riana, Ade; Hänscheid, Heribert; Beer, Ambros J; Lassmann, Michael; Glatting, Gerhard

Establishing measurement traceability for quantitative SPECT imaging

建立定量SPECT成像的测量可追溯性

Robinson, Andrew P; Ferreira, Kelley M; Heetun, Warda; Bardiès, Manuel; Denis-Bacelar, Ana M; Fenwick, Andrew J; Lassmann, Michael; Tipping, Jill; Tran-Gia, Johannes

(131)I therapy for benign thyroid disease: flexible single-time-point dosimetry using population-based model selection with non-linear mixed-effects modelling

(131)I治疗良性甲状腺疾病:基于人群模型选择的灵活单时间点剂量测定法和非线性混合效应模型

Hardiansyah, Deni; Riana, Ade; Hänscheid, Heribert; Jabar, Jaja Muhamad; Beer, Ambros J; Lassmann, Michael; Glatting, Gerhard

Correction: (131)I therapy for benign thyroid disease: flexible single-time-point dosimetry using population-based model selection with non-linear mixed-effects modelling

更正:(131)I 治疗良性甲状腺疾病:采用基于人群的模型选择和非线性混合效应模型的灵活单时间点剂量测定

Hardiansyah, Deni; Riana, Ade; Hänscheid, Heribert; Jabar, Jaja Muhamad; Beer, Ambros J; Lassmann, Michael; Glatting, Gerhard

In silico analysis of radiation-induced double-strand breaks by internal ex vivo irradiation of lymphocytes for 45 alpha- and beta/gamma-emitting radionuclides

利用计算机模拟分析45种α和β/γ发射放射性核素对淋巴细胞进行体外内部照射引起的辐射诱导双链断裂

Salas-Ramirez, Maikol; Lassmann, Michael; Eberlein, Uta

Dosimetry Software for Theranostic Applications: Current Capabilities and Future Prospects

用于诊疗一体化应用的剂量测定软件:现状与展望

Kesner, Adam L; Brosch-Lenz, Julia; Gear, Jonathan; Lassmann, Michael